Similar articles for PMID: 35093911

Year	Number of Results
1996	2
1999	1
2001	2
2002	1
2003	5
2004	3
2005	6
2006	4
2007	3
2008	2
2009	8
2010	5
2011	4
2012	3
2013	6
2014	9
2015	8
2016	11
2017	10
2018	10
2019	8
2020	8
2021	7
2022	11

1

Investigation of Hypersensitivity Reactions in Carboplatin Desensitization Therapy.

Shibata N, Kawakami K, Hisanori S, Kobayashi K, Yunokawa M, Kanao H, Taki I, Murase R, Kamei D, Yamaguchi M. Shibata N, et al. Anticancer Res. 2022 Feb;42(2):1091-1097. doi: 10.21873/anticanres.15571. Anticancer Res. 2022. PMID: 35093911

2

A cohort study of hypersensitivity reaction in patients with epithelial ovarian cancer treated with carboplatin.

Sun T, Li L. Sun T, et al. Int J Gynecol Cancer. 2019 Mar;29(3):566-571. doi: 10.1136/ijgc-2018-000072. Epub 2018 Dec 22. Int J Gynecol Cancer. 2019. PMID: 30833442

3

Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.

Li Q, Cohn D, Waller A, Backes F, Copeland L, Fowler J, Salani R, O'Malley D. Li Q, et al. Gynecol Oncol. 2014 Oct;135(1):90-4. doi: 10.1016/j.ygyno.2014.07.104. Epub 2014 Aug 7. Gynecol Oncol. 2014. PMID: 25110329

4

4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.

Takase N, Matsumoto K, Onoe T, Kitao A, Tanioka M, Kikukawa Y, Yamaguchi S, Fujiwara K, Negoro S. Takase N, et al. Int J Clin Oncol. 2015 Jun;20(3):566-73. doi: 10.1007/s10147-014-0731-1. Epub 2014 Jul 18. Int J Clin Oncol. 2015. PMID: 25030546

5

Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer.

Altwerger G, Florsheim EB, Menderes G, Black J, Schwab C, Gressel GM, Nelson WK, Carusillo N, Passante T, Huang G, Litkouhi B, Azodi M, Silasi DA, Santin A, Schwartz PE, Ratner ES. Altwerger G, et al. J Cancer Res Clin Oncol. 2018 Dec;144(12):2449-2456. doi: 10.1007/s00432-018-2753-y. Epub 2018 Sep 25. J Cancer Res Clin Oncol. 2018. PMID: 30255380

6

Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study.

Gomez R, Harter P, Lück HJ, Traut A, Kommoss S, Kandel M, du Bois A. Gomez R, et al. Int J Gynecol Cancer. 2009 Oct;19(7):1284-7. doi: 10.1111/IGC.0b013e3181a418ff. Int J Gynecol Cancer. 2009. PMID: 19823066

7

Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.

Hesterberg PE, Banerji A, Oren E, Penson RT, Krasner CN, Seiden MV, Wong JT. Hesterberg PE, et al. J Allergy Clin Immunol. 2009 Jun;123(6):1262-7.e1. doi: 10.1016/j.jaci.2009.02.042. J Allergy Clin Immunol. 2009. PMID: 19501233

8

Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study.

Altwerger G, Gressel GM, English DP, Nelson WK, Carusillo N, Silasi DA, Azodi M, Santin A, Schwartz PE, Ratner ES. Altwerger G, et al. Gynecol Oncol. 2017 Jan;144(1):77-82. doi: 10.1016/j.ygyno.2016.09.027. Epub 2016 Oct 24. Gynecol Oncol. 2017. PMID: 27789084

9

Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions.

Lee CW, Matulonis UA, Castells MC. Lee CW, et al. Gynecol Oncol. 2004 Nov;95(2):370-6. doi: 10.1016/j.ygyno.2004.08.002. Gynecol Oncol. 2004. PMID: 15491759 Clinical Trial.

10

[Successful desensitization using cisplatin after carboplatin-associated hypersensitivity reactions in 3 cases with recurrent ovarian carcinoma].

Hosaka M, Ebina Y, Moriwaki M, Hara Y, Araki N, Todo Y, Takeda M, Watari H, Sakuragi N. Hosaka M, et al. Gan To Kagaku Ryoho. 2007 Sep;34(9):1505-8. Gan To Kagaku Ryoho. 2007. PMID: 17876157 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed